Maze Therapeutics, Inc. (MAZE) reporting calendar
Maze Therapeutics, Inc. files periodic reports with the SEC as MAZE on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 17 Jul 2026 – 7 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 12 May 2026
- Reports on record
- 6
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open MAZE market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 12 May 2026 | 42 days | 0001193125-26-219430 |
| 10-K | 31 Dec 2025 | 25 Mar 2026 | 84 days | 0001193125-26-122778 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001193125-25-269689 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0000950170-25-107306 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0000950170-25-071375 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0000950170-25-047208 |
Source: SEC EDGAR company submissions for CIK 0001842295. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.